Clin2
NCT06647901Likely a fitRecruiting

ICG dye imaging for giant cell tumor surgery

Giant Cell Tumor of Bone

Treatments studied

Part of Cancer clinical trials.

This trial uses a special dye (ICG) and a camera to help surgeons see the tumor better during surgery for giant cell tumors of bone in the arms or legs. The goal is to remove all of the tumor while saving as much healthy bone as possible.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
45 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have a giant cell tumor of bone confirmed by biopsy.
  • The tumor is in an arm or leg, and this is the first surgery for it.
  • You have not taken denosumab or bisphosphonates before surgery.
  • You do not have other cancers or severe liver or kidney problems.
  • You are not pregnant or breastfeeding and have no known allergies to the dyes or bone cement used.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07315828Recruiting· Phase 4
ICG imaging to improve surgery for giant cell bone tumors

This trial uses a special dye called indocyanine green (ICG) during surgery to make giant cell bone tumors glow, helping doctors remove them more accurately. It may lead to better surgical outcomes for people with this tumor type.

Shanghai
NCT07315841Recruiting· Phase 4
Dye Imaging for Tenosynovial Giant Cell Tumor Surgery

This trial tests whether a special dye (Indocyanine Green) used during surgery can help doctors see Tenosynovial Giant Cell Tumors more clearly. It may help make the surgery more precise.

Shanghai
NCT06979115Not yet recruiting
Glowing dye to guide removal of bone and soft tissue tumors

This study uses a special dye that makes tumors glow during surgery, helping your surgeon see exactly what to remove and what to leave. It aims to make surgery more precise and safer for people with bone or soft tissue tumors.

Guangzhou, Guangdong
NCT04752137Recruiting· Phase 2
ICG dye imaging during surgery to check tumor edges

This trial tests whether a special dye (ICG) seen during your surgery can help doctors better identify the edges of a tumor in bone or soft tissue. It may help ensure as much of the tumor is removed as safely as possible.

Boston, Massachusetts
NCT07825597Recruiting
Using a special dye to see head and neck cancer during surgery

This trial tests a dye called indocyanine green (ICG) that makes cancer cells glow under a special camera during surgery. It may help doctors remove more cancer and leave healthy tissue alone.

St Louis, Missouri
NCT05645523Recruiting· Early Phase 1
ICG dye mapping to find lymph nodes in some childhood tumors

This early study tests using a special dye (indocyanine green, or ICG) to help surgeons find the correct “sentinel” lymph nodes during surgery in children with certain suspected tumors. If successful, it may improve how doctors remove and check lymph nodes while reducing the chance of missing important areas.

Chicago, Illinois

Hear when a new Giant Cell Tumor of Bone trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.